Skip to main content

Wilson's Disease clinical trials at UC Davis

1 research study open to eligible people

Showing trials for
  • VTX-801 in Adult Patients With Wilson's Disease

    “Become involved in the GATEWAY Clinical Trial (Gene Therapy for Wilson's Disease)”

    open to eligible people ages 18-65

    The objectives of this clinical trial are to assess, for up to 5 years, the safety, tolerability and pharmacological activity of a single ascending doses of VTX-801, a gene therapy, administered intravenously (IV) to adult patients with Wilson's Disease prior to and following background WD therapy withdrawal.

    Sacramento, California and other locations

Last updated: